abrdn Life Sciences InvestorsHQL
Price (close)
$19.27
Market cap
—
P/E
—
Revenue (FY)
—
Net income
—
Dividend yield
11.62%
1-year total return
51.9%
Net margin
—
Revenue growth
—
Debt / equity
—
What abrdn Life Sciences Investors does.
No business description on file yet.
More on HQL.
- abrdn Life Sciences Investors summary
- abrdn Life Sciences Investors financial statements
- abrdn Life Sciences Investors key metrics
- abrdn Life Sciences Investors health scores and style box
- abrdn Life Sciences Investors earnings
- abrdn Life Sciences Investors dividends
- abrdn Life Sciences Investors valuation
- abrdn Life Sciences Investors ownership and insiders
- abrdn Life Sciences Investors peers
Figures from abrdn Life Sciences Investors's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.